Amundi
MED icon

Amundi’s Medifast MED Stock Holding History

Amundi’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,439
Closed -$445K – 1646
2025
Q2 		$445K Hold
30,439
– – ﹤0.01% 1407
2025
Q1 		$398K Buy
30,439
+9,224
+43% +$139K ﹤0.01% 1546
2024
Q4 		$332K Buy
+21,215
New +$394K ﹤0.01% 1644
2023
Q2 		– Sell
-1,884
Closed -$182K – 2094
2023
Q1 		$182K Buy
1,884
+1,321
+235% +$146K ﹤0.01% 1590
2022
Q4 		$68K Sell
563
-127
-18% -$14.8K ﹤0.01% 1656
2022
Q3 		$78K Buy
690
+449
+186% +$64.3K ﹤0.01% 1597
2022
Q2 		$43K Hold
241
– – ﹤0.01% 1552
2022
Q1 		$41K Sell
241
-21,303
-99% -$4.02M ﹤0.01% 1554
2021
Q4 		$4.49M Sell
21,544
-3,047
-12% -$630K ﹤0.01% 1023
2021
Q3 		$4.74M Sell
24,591
-13,419
-35% -$3.3M ﹤0.01% 1018
2021
Q2 		$10.8M Buy
+38,010
New +$10.3M 0.01% 825

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Amundi's MED Position: Q3 2025 in Review

Amundi sold out of Medifast (MED) in Q3 2025, closing a stake of 30,439 shares — an estimated $445K sold.

Amundi first reported a position in MED in Q2 2021 and held it in 11 quarters. The position peaked at $10.8M in Q2 2021. 123 funds tracked by Wall St. Rank hold MED as of Q3 2025.

  • Amundi reported no remaining Medifast position as of Q3 2025 after selling out during the quarter.
  • Amundi sold 30,439 Medifast shares in Q3 2025, an estimated $445K.
  • Amundi first reported a position in Medifast in Q2 2021 and held it in 11 quarters.
  • Amundi's Medifast position peaked at $10.8M in Q2 2021.
  • 123 funds tracked by Wall St. Rank held Medifast as of Q3 2025.

Based on Amundi's 13F filing for Q3 2025, filed 14 Nov 2025.